OK

Omesh Kumar Sethi

Active Director Managing Director DIN 00850162
DIN 00850162 First appointment Oct 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 6 historical roles
Total affiliations 9 Since Oct 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Omesh Kumar Sethi

Data last updated:

Omesh Kumar Sethi is a Managing Director at Standard Pharmaceuticals Ltd (since 2015), Director at Stanvie Industries Private Limited (since 2024) and Director at Sol Medic Limited (since 2019). The companies operate in Pharma, Paper and Chemicals. The largest current company by reported revenue is Standard Pharmaceuticals Ltd at ₹20.17 Cr (FY 2025). Earlier, Omesh Kumar Sethi was an Additional Director at Zenotech Laboratories Limited (2008) and Director at Ranbaxy Drugs Limited (2006–2010) and 4 more.

DIN 00850162
Primary Designation Managing Director
Industry Pharma
First Appointment 18 Oct 2006
Oldest Company Age 30 yrs
Largest company Standard Pharmaceuticals Ltd Β· ₹20.17 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Standard Pharmaceuticals Ltd U24232WB1995PLC075698
Managing Director30 Sep 20151995₹20.17 Cr (FY 2025)Active
Stanvie Industries Private Limited U21001DL2024PTC435710
Director21 Aug 20242024Active
Sol Medic Limited U17210WB2011PLC218319
Director01 Jun 20192011Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zenotech Laboratories Limited L27100TG1989PLC010122
Additional Director31 Jan 20081989₹44.60 Cr (FY 2025)Active
Ranbaxy Drugs Limited U24232GJ1984PLC095288
Director18 Oct 20061984₹12.44 Cr (FY 2016)Amalgamated
Ranbaxy Drugs And Chemicals Company U74899DL1995PLC070691
Director18 Oct 20061995Amalgamated
Rexcel Pharmaceuticals Limited U24231DL1997PLC085491
Director18 Oct 20061997Amalgamated
Solus Pharmaceuticals Limited U74899DL1995PLC065783
Director18 Oct 20061995Amalgamated
Sol Medic Laboratories Limited U51397DL2012PLC232755
Director13 Mar 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Omesh Kumar Sethi

Directorship timeline

Open interactive timeline →
Standard Pharmaceuticals Ltd
Sol Medic Limited
Sol Medic Laboratories Limited
Stanvie Industries Private Limited
Premium access

Shareholding and investment profile for Omesh Kumar Sethi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Omesh Kumar Sethi

Omesh Kumar Sethi currently holds 3 directorships: Standard Pharmaceuticals Ltd (Managing Director, since 30 Sep 2015, revenue β‚Ή20.17 Cr (FY 2025)); Stanvie Industries Private Limited (Director, since 21 Aug 2024); Sol Medic Limited (Director, since 01 Jun 2019).

Omesh Kumar Sethi was first appointed on 18 Oct 2006 as Director at Ranbaxy Drugs Limited. The most recent appointment on record is 21 Aug 2024 at Stanvie Industries Private Limited.

Omesh Kumar Sethi held 6 earlier board appointments: Zenotech Laboratories Limited (Additional Director, 31 Jan 2008 to 31 Dec 2008); Ranbaxy Drugs Limited (Director, 18 Oct 2006 to 24 Jun 2010); Ranbaxy Drugs And Chemicals Company (Director, 18 Oct 2006 to 24 Jun 2010); Rexcel Pharmaceuticals Limited (Director, 18 Oct 2006 to 01 Nov 2010); Solus Pharmaceuticals Limited (Director, 18 Oct 2006 to 01 Nov 2010); and 1 more.

The current boards of Omesh Kumar Sethi's companies include Bhabani Prasad Dey (Standard Pharmaceuticals Ltd), Dwijasis Bhattacharya (Standard Pharmaceuticals Ltd), Tarun Mall Kumar (Standard Pharmaceuticals Ltd), Tarun Mall Kumar (Standard Pharmaceuticals Ltd), Vijayata Sethi (Stanvie Industries Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available